検索結果

研究開発パイプライン | 研究開発活動 | 千寿製薬株式会社

開発進捗状況PROGRESS OF DEVELOPMENT フェーズ1以降の情報を開示しています 開発テーマ対象疾患開発段階（地域） SJP-0132ドライアイ承認（日本） プラノプロフェン抗炎症申請中（ベトナム） SJP-0132ドライアイP3（中国） SJP-0008網膜中心動脈閉塞症P3（日本） SJP-0170緑内障P3（日本） SJP-0154ドライアイP2（日本） SJP-0049アレ...

nufacturing and marketing approval. This clinical trial is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...

nufacturing and marketing approval. This clinical trial is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...

ing and marketing approval. The development of SJP-0008 is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...

ing and marketing approval. The development of SJP-0008 is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...